NO20080650L - Forbindelser omfattende DMXAA for behandling av kreft - Google Patents

Forbindelser omfattende DMXAA for behandling av kreft

Info

Publication number
NO20080650L
NO20080650L NO20080650A NO20080650A NO20080650L NO 20080650 L NO20080650 L NO 20080650L NO 20080650 A NO20080650 A NO 20080650A NO 20080650 A NO20080650 A NO 20080650A NO 20080650 L NO20080650 L NO 20080650L
Authority
NO
Norway
Prior art keywords
dmxaa
cancer
treatment
combinations
compounds
Prior art date
Application number
NO20080650A
Other languages
English (en)
Norwegian (no)
Inventor
Gail Rowlinson-Busza
Colin Green
Lloyd Kelland
Original Assignee
Antisoma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antisoma Plc filed Critical Antisoma Plc
Publication of NO20080650L publication Critical patent/NO20080650L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20080650A 2005-08-26 2008-02-06 Forbindelser omfattende DMXAA for behandling av kreft NO20080650L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0517387.7A GB0517387D0 (en) 2005-08-26 2005-08-26 Combinations for the treatment of cancer
PCT/GB2006/003207 WO2007023307A1 (en) 2005-08-26 2006-08-25 Combinations comprising dmxaa for the treatment of cancer

Publications (1)

Publication Number Publication Date
NO20080650L true NO20080650L (no) 2008-05-13

Family

ID=35198384

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080650A NO20080650L (no) 2005-08-26 2008-02-06 Forbindelser omfattende DMXAA for behandling av kreft

Country Status (16)

Country Link
US (1) US20100104565A1 (de)
EP (1) EP1931331A1 (de)
JP (1) JP2009506020A (de)
KR (1) KR20080048488A (de)
CN (1) CN101296695A (de)
AU (1) AU2006283376A1 (de)
BR (1) BRPI0614964A2 (de)
CA (1) CA2620447A1 (de)
EC (1) ECSP088242A (de)
GB (1) GB0517387D0 (de)
IL (1) IL189377A0 (de)
MA (1) MA29784B1 (de)
NO (1) NO20080650L (de)
RU (1) RU2404765C2 (de)
TN (1) TNSN08057A1 (de)
WO (1) WO2007023307A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002009700A1 (en) 2000-07-28 2002-02-07 Cancer Research Technology Limited Cancer treatment by combination therapy
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
AU2008239594B2 (en) 2007-04-13 2013-10-24 Beth Israel Deaconess Medical Center Methods for treating cancer resistant to ErbB therapeutics
US8287346B2 (en) * 2008-11-03 2012-10-16 Cfph, Llc Late game series information change
JP2016538344A (ja) * 2013-11-19 2016-12-08 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ 癌処置としてのｓｔｉｎｇアゴニストの使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0121285D0 (en) * 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
TWI329112B (en) * 2002-07-19 2010-08-21 Bristol Myers Squibb Co Novel inhibitors of kinases

Also Published As

Publication number Publication date
WO2007023307A1 (en) 2007-03-01
BRPI0614964A2 (pt) 2016-09-13
RU2404765C2 (ru) 2010-11-27
US20100104565A1 (en) 2010-04-29
CN101296695A (zh) 2008-10-29
JP2009506020A (ja) 2009-02-12
KR20080048488A (ko) 2008-06-02
CA2620447A1 (en) 2007-03-01
ECSP088242A (es) 2008-08-29
MA29784B1 (fr) 2008-09-01
TNSN08057A1 (en) 2009-07-14
AU2006283376A1 (en) 2007-03-01
RU2008111493A (ru) 2009-10-10
EP1931331A1 (de) 2008-06-18
IL189377A0 (en) 2008-06-05
GB0517387D0 (en) 2005-10-05

Similar Documents

Publication Publication Date Title
NO20063449L (no) Substituerte heterocykler og deres anvendelse
SE0301010D0 (sv) Novel compounds
EA200970156A1 (ru) Пиридизиноновые производные
EA201170508A1 (ru) Производные 1-амино-2-циклобутилэтилбороновой кислоты
NO20063821L (no) Kinolinderivater for anvendelse som mykobakterielle inhibitorer
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
UA107783C2 (en) Isoindoline compounds for use in treating cancer
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
EA200802050A1 (ru) Новые гетероарилзамещенные ариламинопиридиновые производные в качестве мек ингибиторов
ATE411280T1 (de) Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
EA200870380A1 (ru) Аминотетрагидропираны в качестве ингибиторов дипептидилпептидазы-vi для лечения или предупреждения диабета
NO20085212L (no) Nye pyridinanaloger
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
NO20080650L (no) Forbindelser omfattende DMXAA for behandling av kreft
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
NO20085214L (no) Nye pyridinanaloger
TW200738659A (en) Novel compounds
TW200745122A (en) New compounds I
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
NO20080839L (no) Isotopsubstituerte protonpumpeinhibitorer
EA201201550A1 (ru) Производные альфа-кетоамидов в качестве ингибиторов цистеинпротеаз
GB0407025D0 (en) Novel compounds
IL191670A0 (en) Compounds for the inhibition of apoptosis
ATE462703T1 (de) Bicyclononen-derivate als renin-inhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application